Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Clinical trial NCT06806293 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06806293
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2026-06-29
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.